Cancer Topics
The On-Topic Netowork

Cancer > Arthralgia


Arthralgia
Arthralgia
Arthralgia
Arthralgia
Arthralgia

The following information is about Arthralgia.

Arthralgia Defined

Pain in a joint.

This definition is in context to Cancer. See more contextual defintions for Arthralgia.


Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

Published August 27, 2008, 3:12 pm, News-Medical-Net

Novartis has announced that Gleevec (imatinib mesylate) tablets, (known as Glivec (imatinib) outside the US, Canada and Israel), has been granted priority review status by the US Food and Drug Administration (FDA) as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors (GIST).

Full Story


Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After ...

Published August 27, 2008, 4:00 am, PR Newswire via Yahoo! Finance

Novartis announced today that Gleevec® tablets* has been granted priority review status by the US Food and Drug Administration as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors .

Full Story


Synta Announces Publication Of Elesclomol Mechanism Of Action Results In AACR Journal Molecular Cancer Therapeutics

Published August 26, 2008, 4:15 am, Medical News Today

Synta Pharmaceuticals Corp., (NASDAQ: SNTA) announced the publication of new findings in the American Association for Cancer Research journal, Molecular Cancer Therapeutics that describe the novel mechanism of action of elesclomol: driving programmed cell death (apoptosis) in cancer cells through the selective induction of oxidative stress.

Full Story


Synta Announces Publication of Elesclomol Mechanism of Action Results in AACR Journal Molecular Cancer Therapeutics

Published August 22, 2008, 1:50 pm, Centre Daily Times

Synta Pharmaceuticals Corp., (NASDAQ: SNTA) today announced the publication of new findings in the American Association for Cancer Research journal, Molecular Cancer Therapeutics that describe the novel mechanism of action of elesclomol: driving programmed cell death (apoptosis) in cancer cells through the selective induction of oxidative stress. Elesclomol is currently in a global, pivotal ...

Full Story


Synta Announces Publication of Elesclomol Mechanism of Action Results in AACR Journal Molecular Cancer Therapeutics

Published August 22, 2008, 5:00 am, Business Wire via Yahoo! Finance

LEXINGTON, Mass.----Synta Pharmaceuticals Corp., today announced the publication of new findings in the American Association for Cancer Research journal, Molecular Cancer Therapeutics that describe the novel mechanism of action of elesclomol: driving programmed cell death in cancer cells through the selective induction of oxidative stress.

Full Story


Are you looking for additional Cancer > Arthralgia news? Try our new "Arthralgia News Focus" area.

Off-site Arthralgia Links, User Submitted

The following links have been collected through user bookmark submission in the Arthralgia category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Tue Nov 13

Mon Oct 1

Sun Sep 16

Fri Feb 24

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Arthralgia. If you would like to find related tags we recommend Tag Patterns > Arthralgia

Off-site Arthralgia Research Links

If you still need additional information on Arthralgia then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Cancer

If you know the Cancer Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a